Ramasamy Tamizhselvi

Vellore Institute of Technology University

Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “In vitro and in vivo evaluation of the biofilm-degrading Pseudomonas phage Motto, as a candidate for phage therapy”.

In vitro and in vivo evaluation of the biofilm-degrading Pseudomonas phage Motto, as a candidate for phage therapy

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.12.512010

N/A

0DataRank · unranked

1 citations

Belinda Loh, Dann Turner, Ramasamy Tamizhselvi, Marimuthu Mathankumar, Namasivayam Elangovan +3 more

NLRP3: a new therapeutic target in alcoholic liver disease

Frontiers in Immunology(2023)10.3389/fimmu.2023.1215333

N/A

0DataRank · unranked

47 citations

Tiasha Dasgupta, Venkatraman Manickam, Viswanathan Saraswathi, Ramasamy Tamizhselvi, Subhashini Brahadeeswaran

Circadian disruption and psychostimulants dysregulates plasma acute-phase proteins and circulating cell-free mitochondrial DNA

Brain Behavior & Immunity - Health(2023)10.1016/j.bbih.2023.100659

N/A

0DataRank · unranked

1 citations

Mayur Doke, Jay P. McLaughlin, Thangavel Samikkannu, Ramasamy Tamizhselvi

In vitro and in vivo evaluation of the biofilm-degrading Pseudomonas phage Motto, as a candidate for phage therapy

Frontiers in Microbiology(2024)10.3389/fmicb.2024.1344962

N/A

0DataRank · unranked

19 citations

Belinda Loh, Dann Turner, Ramasamy Tamizhselvi, Marimuthu Mathankumar, Namasivayam Elangovan +3 more